A new diagnostic tool has been developed by researchers at The University of Texas at Austin that can easily, quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue, chikungunya or yellow fever. It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia.
“Many of these diseases are spreading in areas where they weren’t common before,” said Sanchita Bhadra, a research associate in the Department of Molecular Biosciences and first author on the paper. “Having surveillance is important in conjunction with any kind of outbreak, and this method allows a rapid test in the field.”
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Aedes aegypti carries Zika and other devastating viruses that afflict an estimated 100 million people worldwide each year. The species also is closely linked to the tripling of cases of mosquito-borne diseases in the United States since 2004.
The research appears in the journal PLOS Neglected Tropical Diseases.
The tool developed by scientists and students at UT Austin also detects the presence of a biopesticide called Wolbachia, a type of bacteria that keeps mosquitoes from spreading diseases. In countries around the world and in 20 U.S. states where the Aedes aegypti mosquito is found, scientists working in public health agencies have started to infect mosquitoes with Wolbachia by introducing the bacteria into a local mosquito population to help curb transmission of viruses.
Because mosquitoes show no outward signs of having the bacteria – and because existing diagnostic tests are hard to read, expensive and logistically cumbersome – the new tool represents a significant step forward for those hoping to monitor the effectiveness of Wolbachia.
“This test can happen without involving a lot of staff and equipment to make sure Wolbachia is effective and spreading as anticipated,” Bhadra said.
Public health groups trap and kill mosquitoes routinely in conjunction with monitoring efforts, but existing technology requires a complex process to extract nucleic acid from inside mosquitoes, often after they have been dead for days and have started to decay, leading to greater expense and the possibility of more errors in lab tests than the new technology.
The new diagnostic tool uses a smartphone’s camera and a simple test that can be done anywhere. It tests mosquitoes’ nucleic acid without requiring a complicated process to remove it. Officially known as a loop-mediated isothermal amplification and oligonucleotide strand displacement, or LAMP OSD, the probe delivers a simple yes-or-no readout on a cellphone, with accuracy of greater than 97 percent.
In addition to the tests to detect mosquito species and Wolbachia, the team also is exploring use of the technology to easily identify whether trapped mosquitoes are carrying Zika, dengue and other pathogens.
The Latest on: Disease diagnostic tool
via Google News
The Latest on: Disease diagnostic tool
- Machine-learning facilitates selection of a novel diagnostic panel of metabolites for the detection of heart failureon January 10, 2020 at 5:19 am
Ischemic heart disease was an etiology of HFrEF in 57% of patients ... an untargeted metabolomics and ML algorithms can be a promising tool for the diagnostic workup in HFrEF. The combination of ...
- Lyme Disease advocates hope Justin Bieber diagnosis will raise more awareness of devastating diseaseon January 10, 2020 at 12:04 am
Their online assessment tool has helped more than 500 people here in Minnesota. "This is such a silent disease because it's on the inside," Najarian says. But 500 is just a drop in the bucket compared ...
- Justin Bieber's Lyme Disease: An Expert Shares Potential Good News, Possible Complicationson January 9, 2020 at 9:41 am
A day after Bieber revealed that he'd been diagnosed with Lyme, Billboard spoke to a leading expert on the disease.
- Medical Screening And Disease Prevention Deliberated On "Behind The Scenes" With Laurence Fishburneon January 9, 2020 at 4:33 am
Coming soon in an upcoming segment of Behind The Scenes Laurence Fishburne introduces leaders in the medical fields spotlighting screening used in disease diagnosis and prevention. Screening for ...
- Fusion Genomics Receives $1 Million Award to Evaluate Novel Genomic Diagnostics Platform in Collaboration with Sunnybrook Research Instituteon January 9, 2020 at 4:30 am
Fusion Genomics announced today that the company has been awarded $1 million to conduct a prospective clinical study evaluating its ONETest™ comprehensive, novel genomic diagnostics platform. The ...
- Justin Bieber reveals he has Lyme disease - what is the infection?on January 9, 2020 at 2:05 am
The Canadian pop sensation told his 124m Instagram followers he “recently” discovered he had the bacterial infection after a “rough couple years”.
- A brief history of human disease geneticson January 8, 2020 at 11:48 am
Consequently, characterizing the relationship between sequence variation and disease predisposition provides a powerful tool for identifying processes fundamental to disease ... This has been ...
- Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsyon January 8, 2020 at 6:51 am
Today BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Invitae Corporation (NYSE: NVTA) announced that Biogen (NASDAQ: BIIB), Encoded Therapeutics, Neurogene, Praxis Precision Medicines and PTC ...
- Aladdin Healthcare Technologies SE: release a SAAS prototype for Early Diagnosis of Alzheimer's Disease based on blood test resultson January 8, 2020 at 1:39 am
Alzheimer's Disease is one of the most crippling age-related ... analysed by our award-winning AI team and used to develop proprietary AI tools that can assist healthcare professionals to more ...
- URI, BayCare, Butler Hospital launch trial for early detection of Alzheimer's diseaseon January 6, 2020 at 8:59 am
The problem now is that one of the central diagnostic tools for Alzheimer's disease, positron emission tomography (PET) scanning devices, which can detect amyloid protein plaques (a toxic protein that ...
via Bing News